AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Hand-held Collagen Imaging Device

Technology Benefits
Histopathologicalstudy is the gold test for clinical diagnosis, but requires biopsy and canneither be done in vivo nor in real time. UML imaging method is capable ofrapid noninvasive assessment of large skin areas in vivo and is entirelyharmless and nonintrusive. Compared to microscopy techniques, such asconfocal, two photon and second harmonic, UML imaging method provides orders ofmagnitude larger field of view combined with sufficient lateral resolution of15 μm and excellent signal to noise ratio, does not require expensivecomponents and high power densities of light exposure or laser sources.
Detailed Technology Description
A Hand-held device for getting clear and distinct collagen images to check on the health of skin.
Countries
United States
Application No.
WO 2014/165820
*Abstract

The present invention relates to systems and methods or wide-field polarized imaging of the skin. This technology provides quantitative characterization of collagen structures in the skin and can be used to monitor skin treatment. It can be used as a handheld imaging device that generates polarized images at different depths beneath a dermal surface and a data processor to process image data.

*Background
Skin diseasesand degeneration is related to sun exposure, working environment and personalhabits, which can be observed in the change of internal structure of skin.Collagen, which is the major component of the dermal structure, is an importantfactor related to dermal changes.It is criticalto inspect collagen structure and quantitatively define status of skin.Histopathological and immune-histochemical studies are commonly used fordiagnosing diseases and evaluating dermal changes. But these techniques requirebiopsy, which may cause scarring and infection and cannot be performed eitherin vivo or in real time. Collagen content is also a good marker for assessingclinical efficacy of non-ablative fractional treatment (for skin rejuvenation).
*IP Issue Date
None
*IP Type
Other Patent
Country/Region
USA

For more information, please click Here
Mobile Device